Matches in Wikidata for { <http://www.wikidata.org/entity/Q46972019> ?p ?o ?g. }
- Q46972019 description "2007 nî lūn-bûn" @default.
- Q46972019 description "2007 ഒക്ടോബര് 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q46972019 description "2007年の論文" @default.
- Q46972019 description "2007年学术文章" @default.
- Q46972019 description "2007年学术文章" @default.
- Q46972019 description "2007年学术文章" @default.
- Q46972019 description "2007年学术文章" @default.
- Q46972019 description "2007年学术文章" @default.
- Q46972019 description "2007年学术文章" @default.
- Q46972019 description "2007年學術文章" @default.
- Q46972019 description "2007年學術文章" @default.
- Q46972019 description "2007年學術文章" @default.
- Q46972019 description "2007年學術文章" @default.
- Q46972019 description "2007年學術文章" @default.
- Q46972019 description "2007년 논문" @default.
- Q46972019 description "article científic" @default.
- Q46972019 description "article scientific" @default.
- Q46972019 description "article scientifique" @default.
- Q46972019 description "articol științific" @default.
- Q46972019 description "articolo scientifico" @default.
- Q46972019 description "artigo científico" @default.
- Q46972019 description "artigo científico" @default.
- Q46972019 description "artigo científico" @default.
- Q46972019 description "artikel ilmiah" @default.
- Q46972019 description "artikull shkencor" @default.
- Q46972019 description "artikulong pang-agham" @default.
- Q46972019 description "artykuł naukowy" @default.
- Q46972019 description "artículo científico publicado en 2007" @default.
- Q46972019 description "artículu científicu" @default.
- Q46972019 description "bilimsel makale" @default.
- Q46972019 description "bài báo khoa học" @default.
- Q46972019 description "naučni članak" @default.
- Q46972019 description "scienca artikolo" @default.
- Q46972019 description "scientific article published in October 2007" @default.
- Q46972019 description "scientific article published in October 2007" @default.
- Q46972019 description "scientific article published in October 2007" @default.
- Q46972019 description "teaduslik artikkel" @default.
- Q46972019 description "tieteellinen artikkeli" @default.
- Q46972019 description "tudományos cikk" @default.
- Q46972019 description "vedecký článok" @default.
- Q46972019 description "vetenskaplig artikel" @default.
- Q46972019 description "videnskabelig artikel" @default.
- Q46972019 description "vitenskapelig artikkel" @default.
- Q46972019 description "vitskapeleg artikkel" @default.
- Q46972019 description "vědecký článek" @default.
- Q46972019 description "wetenschappelijk artikel" @default.
- Q46972019 description "wissenschaftlicher Artikel" @default.
- Q46972019 description "επιστημονικό άρθρο" @default.
- Q46972019 description "мақолаи илмӣ" @default.
- Q46972019 description "наукова стаття, опублікована в жовтні 2007" @default.
- Q46972019 description "научна статия" @default.
- Q46972019 description "научная статья" @default.
- Q46972019 description "научни чланак" @default.
- Q46972019 description "научни чланак" @default.
- Q46972019 description "מאמר מדעי" @default.
- Q46972019 description "مقالة علمية نشرت في أكتوبر 2007" @default.
- Q46972019 description "অক্টোবর ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46972019 description "บทความทางวิทยาศาสตร์" @default.
- Q46972019 description "სამეცნიერო სტატია" @default.
- Q46972019 name "Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer" @default.
- Q46972019 name "Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer" @default.
- Q46972019 type Item @default.
- Q46972019 label "Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer" @default.
- Q46972019 label "Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer" @default.
- Q46972019 prefLabel "Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer" @default.
- Q46972019 prefLabel "Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer" @default.
- Q46972019 P1433 Q46972019-AEF693EC-FD6D-4E84-85A2-B8428ED03E38 @default.
- Q46972019 P1476 Q46972019-B012531D-E5FF-4951-911B-0F241EA77EC6 @default.
- Q46972019 P2093 Q46972019-0A3DD368-7993-4AE5-A445-A564902B4CEE @default.
- Q46972019 P2093 Q46972019-206FF5EB-5481-4E11-BDFC-0274DDAD75EB @default.
- Q46972019 P2093 Q46972019-3E5E0E5C-915B-4593-92B8-2AA247A2E8E3 @default.
- Q46972019 P2093 Q46972019-58D28A19-93D5-40C3-9F99-4DB7D4390D31 @default.
- Q46972019 P2093 Q46972019-58DB01E0-6A7B-4C50-9D25-BC293034D2DC @default.
- Q46972019 P2093 Q46972019-DB7BF737-6F92-4248-B70F-ECD021D15A7D @default.
- Q46972019 P2093 Q46972019-E39CE411-E188-42BC-B98D-4BF8C4CE7BA8 @default.
- Q46972019 P2093 Q46972019-E8831EC8-0E8B-423D-AEA1-E5A8ACC34466 @default.
- Q46972019 P304 Q46972019-01F1D18B-7CE4-482E-8B28-9255D8816160 @default.
- Q46972019 P31 Q46972019-FE9EC70A-AD12-402D-991D-9D213A089B9B @default.
- Q46972019 P356 Q46972019-CC9D9AFB-C07A-4C03-BED6-EF2896F0002E @default.
- Q46972019 P407 Q46972019-BE3B867C-0B36-4C82-B437-0C6A1B6D2669 @default.
- Q46972019 P433 Q46972019-5E3A63B7-465F-4C59-9870-AFE52E6C3CD8 @default.
- Q46972019 P478 Q46972019-8A32EB04-583D-449C-B28D-5F6DC91A0BF1 @default.
- Q46972019 P50 Q46972019-75E097AD-75D1-434A-99BC-1F606847DF3F @default.
- Q46972019 P50 Q46972019-BFD02817-1EBE-409F-8AB5-7F1AD2FCC520 @default.
- Q46972019 P577 Q46972019-6A7DD8E9-59CB-4907-91DE-AF85B7FD2C73 @default.
- Q46972019 P698 Q46972019-EE9BC0F8-0BB2-4DC2-AE0A-18FEA533E973 @default.
- Q46972019 P8608 Q46972019-CC15EC83-F3FF-4054-8782-D4F34D9EF3E1 @default.
- Q46972019 P921 Q46972019-56526DBE-B550-4B54-A70B-1430902F392E @default.
- Q46972019 P921 Q46972019-FA0F5B84-7445-429A-AA5D-8D31610E14E1 @default.
- Q46972019 P356 JCO.2007.12.3026 @default.
- Q46972019 P698 17909199 @default.
- Q46972019 P1433 Q400292 @default.
- Q46972019 P1476 "Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer" @default.
- Q46972019 P2093 "Alan Sandler" @default.
- Q46972019 P2093 "David Ramies" @default.
- Q46972019 P2093 "Louis Fehrenbacher" @default.
- Q46972019 P2093 "Lowell Hart" @default.
- Q46972019 P2093 "Ming Lin" @default.
- Q46972019 P2093 "Ostap Melnyk" @default.
- Q46972019 P2093 "Philip D Bonomi" @default.